Recombinant human IL-8/CXCL8 protein from NKMAX Co. Ltd.
Search, find, compare suppliers for Recombinant human IL-8/CXCL8 protein products.
| Edit | |
|---|---|
| Product Name | Recombinant human IL-8/CXCL8 protein |
| Description | Domain: 23-99aa. Recombinant human IL-8 was expressed in E. coli and purified by using conventional chromatography techniques. MW: 9 kDa (78aa) confirmed by MALDI-TOF. Purity > 95% by SDS-PAGE. Interleukin-8 (IL-8) is a chemokine, a member of the cytokine family that displays chemotactic activity for specific types of leukocytes. It is a proinflammatory CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. Many cell types, including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, keratinocytes, hepatocytes, chondrocytes, and various tumor cell lines, can produce CXCL8/IL-8 in response to a wide variety of pro-inflammatory stimuli such as exposure to IL-1, TNF, LPS, and viruses |
| Size | 20ug, 100ug, 500ug |
| Concentration | 1mg/ml (determined by BCA assay) |
| Applications | SDS-PAGE |
| Other Names | C-X-C motif chemokine ligand 8, Interleukin-8, IL-8, C-X-C motif chemokine 8, Emoctakin, Granulocyte chemotactic protein 1, GCP-1, Monocyte-derived neutrophil chemotactic factor, MDNCF, Monocyte-derived neutrophil-activating peptide, MONAP, Neutrophil-activating protein 1, NAP-1, Protein 3-10C, T-cell chemotactic factor, Lung giant cell carcinoma-derived chemotactic protein, Tumor necrosis factor-induced gene 1, Lymphocyte derived neutrophil activating peptide, Beta endothelial cell-derived neutrophil activating peptide, Alveolar macrophage chemotactic factor I, SCYB8, LUCT, LECT, TSG-1, AMCF-I, LYNAP, NAF, b-ENA |
| Gene, Accession, CAS # | NCBI: NP_000575.1, UniProt: P10145 |
| Catalog # | ILH0501 |
| Price | $55, $170, $505 |
| Order / More Info | Recombinant human IL-8/CXCL8 protein from NKMAX Co. Ltd. |
| Product Specific References | Kim HR, et al. Anti-cancer activity and mechanistic features of a NK cell activating molecule. (Cancer Immunol Immunother. 2009){https://pubmed.ncbi.nlm.nih.gov/19259669/} |
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124
salesbio@nkmax.com
http://www.nkmaxbio.com
Profile of NKMAX Co. Ltd.